Bortezomib Injection

Bortezomib Injection is anti-cancer formulation which is known to work by inhibiting activity of proteasome. Active compound present in this injection has molecular formula C19H25BN4O4 with molar mass of 384.237 g/mol. It is administered via subcutaneous & IV route by skilled physician or doctor. This injection shows protein binding ability of about 83% with elimination half life of 9 to 15 hours. Bortezomib Injection is metabolized in liver with help of CYP enzymes. It exerts its activity by binding to 26S proteasome site with great affinity & specificity. It is available at highly competitive rates in bulk for our respected customers.